There is no dressing or local anaesthesia required
Once you match the concentration, the unit measurements are identical regardless of vial size
Decision Framework: Which to Choose The choice between AOD-9604 and tesamorelin depends entirely on whether the research wants to engage the GH axis or isolate specific GH effects: Choose AOD-9604 if: Research focuses specifically on lipolytic activity without GH receptor engagement Studies want to avoid IGF-1 elevation and broader GH effects The receptor-independent mechanism is part of the research question Fat metabolism research without confounding GH signaling effects is the goal Choose tesamorelin if: Research focuses on GHRH receptor pharmacology or pituitary GH axis Studies want full GH axis activation including IGF-1 elevation The natural pulsatile GH release pattern is biologically relevant DPP-4-resistant GHRH analog mechanism is the research focus Choose neither (or both) if: Research focuses on different aspects of GH biology Comparative research between upstream and downstream GH peptides is the goal Other GH-related compounds (sermorelin, CJC-1295, ipamorelin) are more relevant see Sermorelin, CJC-1295, and Ipamorelin Research Overview Quality Considerations Both peptides share the same quality framework: Manufactured via Solid-Phase Peptide Synthesis with synthetic amino acids Specific N-terminal modifications incorporated as synthesis steps No animal-derived materials Independent third-party testing by Janoshik Analytical 99% HPLC purity per peptide Mass spectrometry identity confirmation (particularly important for confirming the modifications) For complete quality framework coverage, see How to Verify Peptide Quality and How to Read a Janoshik COA
A WHO consultation identified the most vulnerable groups as elderly individuals, infants, preschool-aged children, and pregnant or lactating women, due to either increased nutritional demands or impaired absorption capacity ( Addressing the prevention of B12 deficiency and its public health implications requires a comprehensive, life-course approach based on integrated strategies targeting early detection, dietary optimisation, and effective supplementation, in order to mitigate the long-term consequences of inadequate cobalamin status ( Intramuscular (IM) injection is the most invasive and costly administration method, requiring trained personnel and clinical visits
This means that oral delivery may also provide good peptide absorption through the stomach mucosa, following intragastric application
